SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950123-18-005779
Filing Date
2018-05-15
Accepted
2018-05-15 16:24:29
Documents
44
Period of Report
2018-05-15

Document Format Files

Seq Description Document Type Size
1 FORM 6-K urgn-6k_6.htm 6-K 24420
2 EX-99.1 urgn-ex991_20180515.htm EX-99 588740
3 EX-99.2 urgn-ex992_7.htm EX-99 155262
4 EX-99.3 urgn-ex993_165.htm EX-99 201314
5 GRAPHIC g201805151932287285711.jpg GRAPHIC 5691
  Complete submission text file 0000950123-18-005779.txt   2524069

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT urgn-20180515.xml EX-101.INS 301691
7 XBRL TAXONOMY EXTENSION SCHEMA urgn-20180515.xsd EX-101.SCH 22944
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE urgn-20180515_cal.xml EX-101.CAL 26413
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE urgn-20180515_def.xml EX-101.DEF 64444
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE urgn-20180515_lab.xml EX-101.LAB 180994
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE urgn-20180515_pre.xml EX-101.PRE 138847
Mailing Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007
Business Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601
UroGen Pharma Ltd. (Filer) CIK: 0001668243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38079 | Film No.: 18836906
SIC: 2834 Pharmaceutical Preparations